¤K¤Q¤K¦~«×¤º¬ì±M¬ìÂå®v¦Ò¸Õµ§¸ÕÃD -- ¦å²G¬ì

(B) 1. ºC©Ê°©Åè¼W´Þ©Ê¯g (chronic myeloproliferative disease)¡A±`¥iÂǥѥզå²yÆP©ÊÁC»ÄÆQúC¤§¬¡©Ê (LAP activity) Ų§O¶EÂ_¡C¤U¦C¨º¤@¯e¯f¡ALAP­°§C¡H
A.¯u©Ê¦h¦å¯g (polycythemia vera rubra)
B.ºC©Ê°©Åè©Ê¥Õ¦å¯g (chronic myelogenous leukemia)
C.­ìµo©Ê¦å¤pªO¼W¦h¯g (primary thrombocytosis)
D.­ìµo©Ê°©ÅèÅÖºû¯g (primary myelofibrosis)
E.°©Åèµw¤Æ¯g (myelosclerosis)
 
(D) 2. ¦³Ãö´c©Ê²O¤Ú½F¡A¤U¦C¨º¤@¶µ±Ô­z¬O¿ù»~¡H
A.´c©Ê²O¤Ú½Fªºµo¥Í­ì¦]»P¯f¬r·P¬V¦³±K¤ÁÃö«Y¡A¤w³QÃҹ꦳Ãöªº¯f¬r¦³ EB ¯f¬r©MHTLV ²Ä¤@«¬
B.«ÕªùÁ³±Û±ìµß (Helicobacter pylori) ¥i¾É­P­G¤§²O¤Ú½F gastric MALT lymphoma (MALToma)
C.Bcl-2 °ò¦]²£ª«¡A¥i§í¨îÀù²Ó­M­ä¤` (apoptosis)¡A¾É­P²O¤Ú½F
D.T-²Ó­M©Ê²O¤Ú½F¡A¸û¤Ö«I¥Ç²O¤Úµ²¥~¤§²Õ´©Î¾¹©x (extra-nodal involvement)
E.¥xÆWªº´c©Ê²O¤Ú½F¡A¬ù 90% ¬°«D»®ªNª÷¤ó²O¤Ú½F¡A10% ¬°Hodgkin's lymphoma
 
(D) 3. ¦³ÃöºKµÊ (splenectomy)¡A¤U¦C¨º¤@¶µ±Ô­z¬O¿ù»~ªº¡H
A.¥Î©óªvÀø¥ý¤Ñ©Ê²yª¬¬õ¦å²y¯g (congenital spherocytosis)
B.¥Î©óªvÀøµÊ¤®¶i (hypersplenism) ©Ò¾É­P¤§¦å²y´î¤Ö¯g (cytopenia)
C.¥Î©óªvÀø¾vª¬²Ó­M©Ê¥Õ¦å¯g (hairy cell leukemia)
D.ºKµÊ«á¡A±`¨£WBC ¼Æ¼W¥[¡A¦ý¬õ¦å²y§ÎºA«h¨S¦³ÅܤÆ
E.20 ·³¥H¤U±wªÌ¡AºKµÊ«á¡A¸û©ö¦³ÄY­«²Óµß·P¬V
 
(C) 4. ¦³Ãö M-GUS (Monoclonal Gammopathies of Uncertain Significance)¡A¤U¦C¨º¤@¶µ±Ô­z¬O¥¿½Tªº¡H
A.¦å²M¤¤¦³ M-protein¡A±`¶W¹L 3 gm/dl
B.°©Å褤¼ß²Ó­M (plasma cell) ¶W¹L 10%
C.§¿¤¤¨S¦³ Bence-Jones protein
D.±`¦³°©Àf¤§·»°©ªº¯f¨_ (osteolytic lesions)
E.·U¦­´Á°µ¤Æ¾ÇªvÀø·U¦n
 
(B) 5. ¬Y¨k©Ê 50 ·³¡AÅç¦åµ²ªG¦p¤U¡G RBC:3.0 M/£gl, Hb:9 g/dl, Hct.:30%, WBC:5000/£gl, Platelet:150 k /£gl, reticulocyte:3.0%¡A¥Õ¦å²y¤ÀÃþµL²§±`¡C½Ð°Ý¨ä¶EÂ_¡A¥H¤U¦C¨º¤@ºØªº¥i¯à©Ê³Ì¤j¡H
A.¦A¥Í¤£¨}©Ê³h¦å (aplastic anemia)
B.«æ©Ê¥X¦å©Ê³h¦å (acute blood loss)
C.¯ÊÅK©Ê³h¦å (iron deficiency anemia)
D.£\«¬®ü¬v©Ê³h¦å (£\-thalassemia))
E.¸­»Ä¤í¯Ê©Ê³h¦å (folate deficiency anemia)
 
(E) 6. ­Y­n¶EÂ_¦­´Á¯ÊÅK²{¶H (early iron deficiency)¡A°µ¤U¦C¨º¤@¶µÀˬd¡A³Ì¬°½T¹ê¦Ó¦³·N¸q¡H
A.Hb ­È¤§´ú¸Õ
B.¬õ¦å²y§ÎºA¤§Æ[¹î
C.¦å²M¬õ¦å²y¥Íªø¿E¯À (erythropoietin) ¤§©w¶q
D.¦å²MÅK (serum iron) ¤§©w¶q
E.¦å²MÅK³J¥Õ (serum ferritin) ¤§©w¶q
 
(C) 7. ¤U¦C¯e¯f¡A§¡·|¤Þ°_·»¦å©Ê³h¦å¡A¨º¤@¶µ¤£ÄÝ©ó¦åºÞ¤º¤§·»¦å (intravascular hemolysis)¡H
A.ABO ¦å«¬¤£¦X¤Þ°_¤§·»¦å (ABO mismatched transfusion)
B.°}µo©Ê©]¶¡©Ê¦å¬õ¯À§¿¯g (paroxysmal nocturnal hemoglobinuria)
C.¥ý¤Ñ©Ê²yª¬¬õ¦å²y¯g (hereditary spherocytosis)
D.G6PD ¤í¯Ê¯g (G6PD deficiency)
E.¤ßŦ佤¤§¸m´«¤â³N«á (valve replacement)
 
(A) 8. ¤U¦C±Ô­z¡A¦óªÌ¬O¿ù»~ªº¡H
A.¦~»´¤H¡A­Y¤ÏÂеo¥ÍÀR¯ß¦å®ê¯g (venous thrombosis) À³¦Ò¼{AT III (antithrombin III) ¼W¥[²{¶H
B.Âಾ©ÊÀù¯g¡A¥iµo¥ÍÀR¯ß¦å®ê¯g¡A¤×¨ä¬O¸¢Àù
C.­ìµo©Ê¦å¤pªO¼W¦h¯g (primary thrombocytosis) ©ö¾É­P¦å®ê¯g
D.Lupus-like anticoagulant ¥i¾É­PÀR¯ß¦å®ê¯g¡A¥ç¥i¤Þ°_¥X¦å²{¶H
E.¿éª`¤j¶q®w¦s¦å (stored blood) ±N¥i¤Þ°_¥X¦å²{¶H
 
(B) 9. ¤U¦C±Ô­z¡M¨º¤@¶µ¬O¤£¥¿½Tªº¡H
A.¥¿±`¤H¦å¤¤¦³ vWF (von Willebrand factor) 10 mg/L
B.ÄY­«©Ê¥Ò«¬¦å¤Í¯f±wªÌ¨ä PT ¤Î PTT §¡©µªø
C.¥¿±`¤§¤î¦å¤Î¾®¦å¹Lµ{¡A»Ý¦å¤¤³Ì¤Ö¦³²Ä¤K¾®¦å¦]¤l 25% ¥H¤W
D.¦å¤¤²Ä¤K¾®¦å¦]¤l¤§¥b°I´Á¡A¶È¦³ 8~10 ¤p®É
E.·í¨xŦ¹ê½è¯fÅÜ (parenchymal disorder)¡A²Ä¤@­Ó´î¤Öªº¦å²G¾®©T¦]¤l¬°²Ä¤C¦]¤l
 
(D) 10. «æ©Ê¥Õ¦å¯f¡A¨ã¦³¤U¦C¨º¤@ºØ¬V¦âÅ骺ÅܤơA¹w«á¸û¦n¡H (µù¡GAML:«æ©Ê°©Åè©Ê¥Õ¦å¯f¡MALL:«æ©Ê²O¤Ú©Ê¥Õ¦å¯f) (1) ALL t(9,22)¡M(2) ALL t(8,14)¡M(3) AML t(9,22)¡M(4) AML t(15,17)
A.1, 2, 3
B.1, 3
C.2, 4
D.4
E.1, 2, 3, 4
 


< ¤K¤Q¤K¦~«×¸ÕÃD¥Ø¿ý >